A new form of drug drastically improves survival rates of younger women with the most common type of breast cancer, researchers said on Saturday, citing the results of an international clinical trial.
The findings, presented at the annual meeting of the American Society of Clinical Oncology in Chicago, showed that the addition of cell-cycle inhibitor ribociclib increased survival rates to 70 percent after three-and-a-half years.
The mortality rate was 29 percent less than when patients, all under 59 and pre-menopausal, were randomly assigned a placebo.
Lead author Sara Hurvitz said the study focused on a form of breast cancer that is fueled by the hormone estrogen and which accounts for two-thirds of all cases among younger women.
It is generally treated by therapies that block the hormone’s production.
“You actually can get synergy, or a better response, better cancer kill, by adding one of these cell-cycle inhibitors” on top of the hormone blocking therapy, Hurvitz said.
The drug works by inhibiting the activity of cancer-cell promoting enzymes. The treatment is less toxic than traditional chemotherapy, because it more selectively targets cancerous cells, blocking their ability to multiply.
Though advanced breast cancer is less common among younger women, its incidence grew 2 percent per year in the US between 1978 and 2008 for women aged 20 to 39, a previous study showed.
The new trial, which looked at more than 670 cases, included only women who had advanced cancer — stage four — for which they had not received prior hormone-blocking therapy.
“These are patients who tend to be diagnosed later, at a later stage in their disease, because we don’t have great screening modalities for young women,” Hurvitz said.
In addition, patients who develop breast cancer early tend to have more complex cases.
A pill is administered daily for 21 days followed by seven days off to allow the body time to recover, since two-thirds of patients have a moderate to severe drop in white cell count.
Jamie Bennett, a spokeswoman for Novartis, which markets the drug under the brand name Kisqali and funded the research, said it cost US$12,553 for a 28-day dose.
There is no cure for metastatic breast cancer and the majority of the women on the drug will require some form of therapy for the rest of their lives.
Oncologist Harold Burstein of the Dana-Farber Cancer Institute in Boston, who was not involved in the research, said it was “an important study,” having established that the use of the drug “translates into a significant survival benefit for women.”
“Hopefully, these data will enable access for this product for more women around the world, particularly in healthcare systems which assess value rigorously as part of their decisions for national access to drugs,” Burstein added.
Yemen’s separatist leader has vowed to keep working for an independent state in the country’s south, in his first social media post since he disappeared earlier this month after his group briefly seized swathes of territory. Aidarous al-Zubaidi’s United Arab Emirates (UAE)-backed Southern Transitional Council (STC) forces last month captured two Yemeni provinces in an offensive that was rolled back by Saudi strikes and Riyadh’s allied forces on the ground. Al-Zubaidi then disappeared after he failed to board a flight to Riyadh for talks earlier this month, with Saudi Arabia accusing him of fleeing to Abu Dhabi, while supporters insisted he was
The Chinese Embassy in Manila yesterday said it has filed a diplomatic protest against a Philippine Coast Guard spokesman over a social media post that included cartoonish images of Chinese President Xi Jinping (習近平). Philippine Coast Guard spokesman Jay Tarriela and an embassy official had been trading barbs since last week over issues concerning the disputed South China Sea. The crucial waterway, which Beijing claims historic rights to despite an international ruling that its assertion has no legal basis, has been the site of repeated clashes between Chinese and Philippine vessels. Tarriela’s Facebook post on Wednesday included a photo of him giving a
‘MOBILIZED’: While protesters countered ICE agents, Minnesota Governor Tim Walz activated the state’s National Guard to ‘support the rights of Minnesotans’ to assemble Hundreds of counterprotesters drowned out a far-right activist’s attempt to hold a small rally in support of US President Donald Trump’s latest immigration crackdown in Minneapolis, Minnesota, on Saturday, as the governor’s office announced that National Guard troops were mobilized and ready to assist law enforcement, although not yet deployed to city streets. There have been protests every day since the US Department of Homeland Security (DHS) ramped up immigration enforcement in the Twin Cities of Minneapolis and Saint Paul by bringing in more than 2,000 federal officers. Conservative influencer Jake Lang organized an anti-Islam, anti-Somali and pro-US Immigration and Customs Enforcement
NASA on Saturday rolled out its towering Space Launch System (SLS) rocket and Orion spacecraft as it began preparations for its first crewed mission to the Moon in more than 50 years. The maneuver, which takes up to 12 hours, would allow the US space agency to begin a string of tests for the Artemis 2 mission, which could blast off as early as Feb. 6. The immense orange and white SLS rocket, and the Orion vessel were slowly wheeled out of the Vehicle Assembly Building at the Kennedy Space Center in Florida, and painstakingly moved 6.5km to Launch Pad 39B. If the
RSS